2018

• Patra, Kalicharan; Soosaipillai, Antoninus; Sando, Sigrid Botne; Lauridsen, Camilla; Berge, Guro; Møller, Ina. (2018) Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease. Alzheimer's Research & Therapy
  Vitenskapelig artikkel
• Twohig, Daniel; Rodriguez-Vieitez, Elena; Sando, Sigrid Botne; Berge, Guro; Lauridsen, Camilla; Møller, Ina. (2018) The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease. Acta neuropathologica communications
  Vitenskapelig artikkel

2017

• Almdahl, Ina; Lauridsen, Camilla; Selnes, Per; Kalheim, Lisa Flem; Coello, Christopher; Gajdzik, Beata. (2017) Cerebrospinal fluid levels of amyloid beta 1-43 mirror 1-42 in relation to imaging biomarkers of Alzheimer's disease. Frontiers in Aging Neuroscience
  Vitenskapelig artikkel
• Lauridsen, Camilla; Sando, Sigrid Botne; Møller, Ina; Berge, Guro; Pomary, Precious Kwadzo; Grøntvedt, Gøril Rolfseng. (2017) Cerebrospinal fluid Aβ43 is reduced in early-onset compared to late-onset Alzheimer's disease, but has similar diagnostic accuracy to Aβ42. Frontiers in Aging Neuroscience
  Vitenskapelig artikkel

2016

• Berge, Guro; Sando, Sigrid Botne; Albrektsen, Grethe; Lauridsen, Camilla; Møller, Ina; Grøntvedt, Gøril Rolfseng. (2016) Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy controls: a two year follow-up study. BMC Neurology
  Vitenskapelig artikkel
• Lauridsen, Camilla; Sando, Sigrid Botne; Shabnam, Adiba; Møller, Ina; Berge, Guro; Grøntvedt, Gøril Rolfseng. (2016) Cerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study. Frontiers in Aging Neuroscience
  Vitenskapelig artikkel

2015

• Berge, Guro; Lauridsen, Camilla; Sando, Sigrid Botne; Holder, Daniel Joseph; Møller, Ina; Aasly, Jan. (2015) Effect of tween-20 on core biomarkers measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy control individuals. Journal of Alzheimer's Disease
  Vitenskapelig artikkel